BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4126382)

  • 1. Kinetic scheduling of vincristine (NSC-67574) and bleomycin (NSC-125066) in patients with lung cancer and other malignant tumors.
    Livingston RB; Bodey GP; Gottlieb JA; Frei E
    Cancer Chemother Rep; 1973 Apr; 57(2):219-24. PubMed ID: 4126382
    [No Abstract]   [Full Text] [Related]  

  • 2. Bleomycin in the treatment of metastatic cancer.
    Depierre A
    Prog Biochem Pharmacol; 1976; 11():195-204. PubMed ID: 63964
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II study of the failure of vincristine and bleomycin for previously treated children with metastatic neuroblastoma: a report from the Childrens Cancer Study Group.
    Bernstein ID; Evans AE; Finklestein J; Klemperer M; Hittle R; Leikin S; Hammond GD
    Cancer Treat Rep; 1978 Aug; 62(8):1201-2. PubMed ID: 80272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitomycin C, vincristine, and bleomycin therapy for advanced cervical cancer.
    Baker LH; Opipari MI; Wilson H; Bottomley R; Coltman CA
    Obstet Gynecol; 1978 Aug; 52(2):146-50. PubMed ID: 79991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vinblastine (NSC-49842) and bleomycin (NSC-125066) therapy for disseminated testicular tumors.
    Spigel SC; Coltman CA
    Cancer Chemother Rep; 1974; 58(2):213-6. PubMed ID: 4133838
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination chemotherapy with bleomycin (NSC-125066), vincristine (NSC-67574), and methotrexate (NSC-740) plus split-course radiotherapy in the treatment of non-oat-cell bronchogenic carcinoma.
    Samuels ML; Barkley HT; Holoye PY; Rosenberg PJ; Smith TL
    Cancer Chemother Rep; 1975; 59(2 Pt 1):377-83. PubMed ID: 50124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy with three marginally effective agents, CCNU, vincristine, and bleomycin, in the treatment of stage III melanoma.
    De Wasch G; Bernheim J; Michel J; Lejeune F; Kenis Y
    Cancer Treat Rep; 1976 Sep; 60(9):1273-6. PubMed ID: 65222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COMB (cyclophosphamide, oncovin, methyl-CCNU, and bleomycin): a four-drug combination in solid tumors.
    Livingston RB; Einhorn LH; Bodey GP; Burgess MA; Freireich EJ; Gottlieb JA
    Cancer; 1975 Aug; 36(2):327-32. PubMed ID: 50870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bleomycin for malignant tumours of the genitals of the male (author's transl)].
    Rathert P; Terhorst B; Lutzeyer W
    Urologe A; 1974 Mar; 13(2):67-71. PubMed ID: 4134047
    [No Abstract]   [Full Text] [Related]  

  • 10. Bleomycin (NSC-125066) therapy of responsive solid tumors.
    Durkin WJ; Pugh RP; Jacobs E; Sadoff L; Pajak T; Bateman JR
    Oncology; 1976; 33(5-6):260-4. PubMed ID: 68454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of disseminated germinal tumors of the testis--comparison of vinblastine and bleomycin with vincristine, bleomycin, and actinomycin D.
    Spigel SC; Stephens RL; Haas CD; Jones HS; Lehane D; Moon TE; Coltman CA
    Cancer Treat Rep; 1978 Jan; 62(1):129-30. PubMed ID: 75064
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antiblastic chemotherapy and surgery in the treatment of cancer of the penis].
    Luciani L; Muraro GB; Menichelli E; Rizzo M
    Minerva Urol; 1977; 29(6):273-7. PubMed ID: 77473
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cytostatic therapy of tumors under conditions of partial synchronisation with particular reference to malignant tumors of the testicle (author's transl)].
    Körner F; Lund S; Jonas U
    MMW Munch Med Wochenschr; 1975 Aug; 117(34):1345-8. PubMed ID: 52114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy with bleomycin and some immunological implications.
    Barduagni A; Marolla A; Calabresi F; Terzoli E
    Prog Biochem Pharmacol; 1976; 11():185-94. PubMed ID: 63963
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients.
    Samson MK; Baker LH; Fraile RJ; Izbicki RM; Vaitkevicius VK
    Cancer Treat Rep; 1977; 61(1):59-64. PubMed ID: 67895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitomycin-associated lung disease.
    Gunstream SR; Seidenfeld JJ; Sobonya RE; McMahon LJ
    Cancer Treat Rep; 1983 Mar; 67(3):301-4. PubMed ID: 6187452
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of cervical carcinoma with methotrexate, bleomycin and vincristine.
    Behnam K; Lewis GC; Lee JH; Looka MH
    Cancer Clin Trials; 1981; 4(1):75-9. PubMed ID: 6163568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-evaluation of the combination of CCNU, vincristine, and bleomycin in the treatment of malignant disseminated melanoma.
    Abele R; Bernheim J; Cumps E; Buyse M; Kenis Y
    Cancer Treat Rep; 1981; 65(5-6):505-6. PubMed ID: 6165474
    [No Abstract]   [Full Text] [Related]  

  • 19. Preliminary trials with a combination of adriamycin (NSC-123127) and bleomycin (NSC-125066) in adult malignancies.
    Tormey DC; Bergevin P; Blom J; Petty W
    Cancer Chemother Rep; 1973; 57(4):413-8. PubMed ID: 4128422
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental chemotherapy in carcinoma of the cervix.
    Papadimitriou G; Razis D; Panopoulos C; Lappas C; Gnafakis N
    Int Surg; 1974 Sep; 59(9):472-5. PubMed ID: 4137657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.